Ming Yan, Chief Technology Officer at Cytek Biosciences, Inc. (CTKB), sold 22,684 shares at $7.19 ($162K) on 2023-05-19, disclosed to the SEC on 2023-05-19.
Scheduled sale ($162k) by Chief Technology Officer under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $6.69 | 772 | $5K | 3.2% |
| 2 | $6.69 | 1,912 | $13K | 7.9% |
| 3 | $7.19 | 20,000 | $144K | 88.9% |
| Total | $7.13 avg | 22,684 | $162K | 100% |
| Filing → |
| CTKB | SELL | 2024-03-19 | $270K | — | Filing → |
| CTKB | SELL | 2023-12-21 | $189K | — | Filing → |
| CTKB | SELL | 2023-11-21 | $121K | — | Filing → |